---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272253776.md"
description: "ZHIFEI-BIOL: CA111 injection has entered Phase I clinical trials"
datetime: "2026-01-12T10:35:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272253776.md)
  - [en](https://longbridge.com/en/news/272253776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272253776.md)
---

# 

ZHIFEI-BIOL: CA111 injection enters Phase I clinical trial

### Related Stocks

- [300122.CN](https://longbridge.com/en/quote/300122.CN.md)

## Related News & Research

- [ZAWYA: Joramco rewards employees with up to 12 weeks’ bonus](https://longbridge.com/en/news/287035395.md)
- [08:47 ETRevive Unveils Major Revive AI Upgrade To Help Agents Show Homeowners Their True Selling Potential](https://longbridge.com/en/news/287068305.md)
- [Canadian Goldfields Closes Acquisition of Newton Gold Property in Ontario | CGMXF Stock News](https://longbridge.com/en/news/287067838.md)
- [13:00 ETBucked Up® Launches Summer Lemonades: Three Limited Edition Pre-Workout Flavors Built for the Season](https://longbridge.com/en/news/287099042.md)
- [Michelin partners with Syntetica to scale nylon recycling technology](https://longbridge.com/en/news/287184210.md)